Personas / Equipo Humano

Cinzia Emilia Lavarino

Buscador de publicaciones

Publicaciones

  • Acosta S, Lavarino C, Paris R, Garcia I, de Torres C, Rodríguez E, Beleta H and Mora J.

    Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells

    BMC DEVELOPMENTAL BIOLOGY . 9: 12-12. Nº de citas: 50

    [doi:10.1186/1471-213X-9-12]

  • Lavarino C, Cheung NK, Garcia I, Domenech G, de Torres C, Alaminos M, Rios J, Gerald WL, Kushner B, LaQuaglia M and Mora J.

    Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

    BMC Cancer . 9: 44-44. Nº de citas: 27

    [doi:10.1186/1471-2407-9-44]

  • Lavarino C, Garcia I, Mackintosh C, Cheung NK, Domenech G, Ríos J, Perez N, Rodríguez E, de Torres C, Gerald WL, Tuset E, Acosta S, Beleta H, de Alava E and Mora J.

    Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status

    BMC MEDICAL GENOMICS . 1: 36-36. Nº de citas: 11

    [doi:10.1186/1755-8794-1-36]

  • Mora J, Lavarino C, Alaminos M, Cheung NK, Ríos J, de Torres C, Illei P, Juan G and Gerald WL.

    Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

    GENES CHROMOSOMES & CANCER . 46(4): 385-396. Nº de citas: 7

    [doi:10.1002/gcc.20421]

  • Coma S, Noe V, Lavarino C, Adán J, Rivas M, López-Matas M, Pagan R, Mitjans F, Vilaró S, Piulats J and Ciudad CJ.

    Use of siRNAs and antisense oligonucleotides against survivin RNA to inhibit steps leading to tumor angiogenesis.

    Oligonucleotides . 14(2): 100-113. Nº de citas: 56

    [doi:10.1089/1545457041526290]

  • Tamborini E, Della Torre G, Lavarino C, Azzarelli A, Carpinelli P, Pierotti MA and Pilotti S.

    Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas.

    INTERNATIONAL JOURNAL OF CANCER . 92(6): 790-796. Nº de citas: 43

    [doi:10.1002/ijc.1271]

  • Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA and Pilotti S.

    Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors.

    LABORATORY INVESTIGATION . 81(6): 833-844. Nº de citas: 91

    [doi:10.1038/labinvest.3780293]

  • Lavarino C, Pilotti S, Oggionni M, Gatti L, Perego P, Bresciani G, Pierotti MA, Scambia G, Ferrandina G, Fagotti A, Mangioni C, Lucchini V, Vecchione F, Bolis G, Scarfone G and Zunino F.

    p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma.

    JOURNAL OF CLINICAL ONCOLOGY . 18(23): 3936-3945. Nº de citas: 124

    [doi:10.1200/JCO.2000.18.23.3936]

  • Butò S, Pierotti MA, Tamborini E, Della Torre G, Lavarino C, Rilke F and Pilotti S.

    Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.

    DIAGN MOL PATHOL . 8(3): 125-130. Nº de citas: 14

    [doi:10.1097/00019606-199909000-00004]

  • Di Palma S, Corletto V, Lavarino C, Birindelli S and Pilotti S.

    Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland.

    VIRCHOWS ARCHIV . 434(4): 361-365. Nº de citas: 39

    [doi:10.1007/s004280050353]